Navigation Links
UBC researchers to lead $4.7-million study on early-stage oral cancer
Date:5/27/2011

Researchers from the University of British Columbia's Faculties of Medicine, Science and Dentistry are leading a $4.7-million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers.

Funded by the Terry Fox Research Institute, the Canadian Optically Guided Approach for Oral Lesions Surgical Trial, or COOLS Study, involves universities and hospitals in nine Canadian cities. Findings from the study could revolutionize clinical practice here and around the world.

According to the Canadian Cancer Society, an estimated 3,400 Canadians are diagnosed with oral cancer every year. In 2010, the estimated number of deaths due to oral cancer was 1,150. Currently, about 30 per cent of patients who receive oral surgery have their cancer recur. The COOLS Study will investigate the effectiveness of a fluorescence visualization, or "blue light," to distinguish between healthy tissues from tumours or pre-cancerous cells in the mouth. Under the blue light, normal tissue generates a fluorescence which is absent in tumour or pre-cancerous tissue.

"In work we've conducted to date in Vancouver, there has been almost no recurrence where surgery followed the contour of the lesion shown by using FV-guided surgery. Working together with surgeons, pathologists, research staff and scientists, this TFRI-funded study will enable us to test the approach on a broader cohort of patients at sites across the country and obtain the evidence required to change current practice." says principal investigator Dr. Catherine Poh, a senior scientist with BC Cancer Agency, an associate professor at the UBC Faculty of Dentistry and a consulting dentist at Vancouver General Hospital.

"Our surgical community has expressed great interest in participating in this trial which provides an unique and important opportunity to assess a surgical intervention in a controlled prospective manner across many sites," says principal investigator Dr. Scott Durham, head of the division of otolaryngology at Vancouver General Hospital and a clinical professor at UBC's Faculty of Medicine. The study aims to build a network of clinicians, pathologists and research staff across the country to fight oral cancer.

"This study will have an immediate impact on practice if the study turns out the way we hope," says principal Investigator Dr. Miriam Rosin, a senior scientist with the BC Cancer Agency who holds joint appointments at UBC and Simon Fraser University. "If the study is successful, it will help to reduce the number of deaths from oral cancer as well as to improve the quality of life for people living with this disease. Working with scientists, we will have this new approach ready to disseminate to the surgical community at large and even globally."

The study's lead investigators also include Calum Macaulay, a clinical associate professor at the UBC Faculty of Medicine and an associate member in Medical Physics in the UBC Faculty of Science; and Stuart Peacock, an associate professor at UBC's School of Population and Public Health in the Faculty of Medicine.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Researchers evaluate red wine compound for treating concussions in pro boxers
2. Researchers Find Cousin of Hepatitis C Virus in Dogs
3. Researchers discover link between obesity gene and breast cancer
4. Mount Sinai researchers discover possible new target for sarcoma treatment and prevention
5. Researchers connect electrical brain disturbances to worse outcomes following neurotrauma
6. Pitt researchers build a better mouse model to study depression
7. Researchers discover that lymphocyte count indicates prognosis of patients with renal cell carcinoma
8. Researchers home in on genetic signature of esophageal cancer
9. Legendary Hollywood directors and renowned researchers awarded 2011 Dan David Prizes
10. Columbia researchers work to prevent blindness from age-related macular degeneration
11. Hebrew University researchers show octopuses make some pretty good moves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... over twenty-four years, Doctors on Liens has published a directory of the top ... care. When the company started in 1997, the directory was a single page focusing ... now ten-page directory features a vast array of medical specialists stretching from Sacramento ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to ... Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to ... drug plan (Part D) need to make changes during this period order for their ...
(Date:12/2/2016)... NY (PRWEB) , ... December 02, 2016 , ... More ... school and while 84 percent of parents report speaking with their child about sex ... and sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre ... unique properties including its unmatched natural purity of just 6 ppm TDS (Total Dissolved ... , Nothing Water has been available in several ShopRite and FoodTown stores in NJ ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare ... the honor of being selected as winners of multiple ... Healthcare Executives Website at the PLATINUM level, Blue Zones ... Module at the GOLD Level, and our proprietary 3ConneX ... At Simpson Healthcare Executives, we are excited to showcase ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
(Date:12/2/2016)... 2, 2016 Allergan plc (NYSE: AGN ... on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a variable ... Company will repurchase $10 billion of its ordinary shares. Approximately ...
Breaking Medicine Technology: